Navigating lot-specific analytical documentation is critical for maintaining consistency in preclinical growth factor assays. PX1 Research provides comprehensive Certificate of Analysis (COA) documentation for every batch of Tesamorelin, utilizing independent ISO 17025 accredited laboratory testing to verify chemical identity, sequence purity, and low endotoxin thresholds.
Navigating lot-specific analytical documentation is critical for maintaining consistency in preclinical growth factor assays. PX1 Research provides comprehensive Certificate of Analysis (COA) documentation for every batch of Tesamorelin, utilizing independent ISO 17025 accredited laboratory testing to verify chemical identity, sequence purity, and low endotoxin thresholds.
A tesamorelin coa (Certificate of Analysis) is a lot-specific analytical document confirming the identity, purity, and sequence integrity of the synthetic growth hormone-releasing hormone (GHRH) analog. Valid COAs for tesamorelin provide reverse-phase high-performance liquid chromatography (RP-HPLC) chromatograms demonstrating ≥99% purity, electrospray ionization mass spectrometry (ESI-MS) verifying exact molecular weight, and chromogenic LAL endotoxin testing results ensuring compliant bioburden limits.
When auditing analytical documentation for Tesamorelin, research facilities must ensure that the certificate details batch-specific data rather than generic template specifications. Every legitimate document issued by an independent ISO 17025 accredited laboratory displays the precise lot number matching the vial label, the assay date, testing methodology parameters, and raw chromatographic outputs. Omission of mass spectra or HPLC retention peak integrations invalidates the utility of the document for rigorous scientific controls.
Laboratory researchers rely on verified documentation to eliminate confounding variables in experimental setups. Unverified structural variants, synthesis truncated sequences, or counter-ion contaminants can alter receptor binding affinity or produce non-specific biological responses in downstream assays. Requesting verified COA documentation prior to experimental integration is standard protocol across institutional research facilities.
Tesamorelin is a synthetic 44-amino-acid peptide stabilized by a trans-3-hexenoic acid group attached to its N-terminal tyrosine residue. This structural modification enhances its enzymatic resistance against dipeptidyl peptidase-4 (DPP-IV) degradation compared to native human growth hormone-releasing hormone (GHRH 1-44). In preclinical models, this extended plasma half-life permits sustained signaling through the GHRH receptor located on pituitary somatotrophes.
Preclinical studies suggest that Tesamorelin selectively binds to GHRH receptors, stimulating the synthesis and pulsatile secretion of endogenous growth hormone (GH), which subsequently elevates circulation of insulin-like growth factor 1 (IGF-1). Because it preserves the natural negative feedback loop mediated by somatostatin, its activity reflects endogenous neuroendocrine regulation more closely than direct GH receptor agonists.
Investigational applications involving Tesamorelin span metabolic regulation, ectopic lipid accumulation, cellular repair mechanisms, and body composition parameters in rodent and non-human primate models. Researchers examining the GHRH receptor signaling axis often consult our broader research peptide library to evaluate complementary compounds affecting somatotrophic feedback loops.
High-Performance Liquid Chromatography (HPLC) serves as the industry standard for quantifying chemical purity in synthetic peptides. During RP-HPLC testing of Tesamorelin, the peptide sample is injected into a hydrophobic stationary phase column and eluted using a gradient mobile phase. Purity is determined by integrating the area under the curve (AUC) of the principal peak relative to total detected peaks at 214 nm, the characteristic absorbance wavelength for peptide bonds.
A compliant tesamorelin coa must display a clear baseline with minimal secondary peak generation. Minor peaks elevated above baseline typically represent synthesis-related impurities, such as deletion sequences (missing one or more amino acids) or oxidation products. PX1 Research mandates that every batch achieves an HPLC purity threshold of ≥99.0%, ensuring experimental reproducibility across cell culture and in vitro biochemical models.
Electrospray Ionization Mass Spectrometry (ESI-MS) complements HPLC by confirming molecular identity. ESI-MS measures the mass-to-charge ratio (m/z) of ionized molecules. Tesamorelin possesses a theoretical monoisotopic molecular mass of approximately 5135.9 Da. Comparing the observed m/z peaks against the calculated theoretical mass confirms that the correct sequence was assembled without incorrect amino acid substitutions.
Bacterial endotoxins, primarily lipopolysaccharides (LPS) derived from Gram-negative bacterial outer membranes, represent a significant contamination hazard in synthesized peptides. Even minute trace amounts of endotoxin in lyophilized peptides can induce non-specific inflammatory cytokine release, cytotoxicity, or altered gene expression in primary cell cultures and tissue preparations.
To ensure bioburden control, third-party testing employs the Limulus Amebocyte Lysate (LAL) assay—typically using kinetic chromogenic or turbidimetric detection methods. Endotoxin levels are measured in Endotoxin Units per milligram (EU/mg). Standard specifications for research-grade peptides require endotoxin levels to remain well below strict regulatory threshold criteria.
PX1 Research integrates rigorous LAL screening into every quality control workflow. Detail regarding our microbiological testing processes and safety thresholds can be found in our technical guide on endotoxin testing standards. Reviewing low endotoxin scores on a batch-specific COA provides investigators with assurance that observed cellular responses stem solely from peptide activity.
When designing protocols to investigate GHRH receptor activity, research teams often evaluate several structurally distinct peptides within the secretagogue class. Comparing structural modifications, receptor binding kinetics, and half-life parameters helps determine the appropriate agent for specific experimental designs.
Tesamorelin features the 44-amino-acid GHRH sequence stabilized with an N-terminal hexenoyl group, making it exceptionally stable for targeting hepatic metabolic markers and adipose tissue signaling. In contrast, Sermorelin represents a truncated 29-amino-acid fragment (GHRH 1-29) containing the essential catalytic core of native GHRH, characterized by a shorter terminal half-life. Meanwhile, CJC-1295 No DAC utilizes a modified 29-amino-acid chain (Tetrasubstituted GRF 1-29) with four amino acid substitutions that resist enzymatic cleavage, extending its signaling duration without covalent plasma binding. For synergistic secretagogue models, researchers frequently study GHRH analogs alongside GHRP class peptides like Ipamorelin.
Selecting among these compounds depends on whether an assay requires short-duration physiological pulses or sustained GHRH receptor occupancy. Detailed comparative data and receptor binding characteristics across all growth hormone secretagogues are cataloged within our comprehensive all research peptides directory.
Lyophilized Tesamorelin displays high stability when stored at standard deep-freeze temperatures (-20°C to -80°C), protected from atmospheric moisture and light exposure. Upon receipt of a shipment, vials should be logged into facility inventory alongside their lot-matched COA and stored in an environment minimizing temperature fluctuations.
For laboratory reconstitution, researchers should allow the vial to equilibrate to room temperature before adding sterile diluents to prevent condensation formation inside the container. Recommended diluents include sterile bacteriostatic water (0.9% benzyl alcohol) or sterile physiological saline, depending on downstream assay compatibility requirements. Reconstitution should involve gently swirling or rolling the vial rather than vigorous shaking to prevent mechanical shear stress and peptide aggregation.
Once dissolved, reconstituted Tesamorelin solutions should be aliquoted into single-use microcentrifuge tubes to avoid repeated freeze-thaw cycles. Aliquots should be maintained at 2°C to 8°C for short-term experimentation (typically up to 7–14 days, depending on diluent preservation) or stored at -80°C for extended research timelines. For deeper technical protocols on maintaining peptide integrity, review our documentation on peptide storage and handling.
PX1 Research operates with an uncompromising focus on chemical purity and analytical transparency. All peptides, including Tesamorelin, are synthesized in state-of-the-art GMP-compliant facilities located within the United States. Adherence to rigorous USA manufacturing standards ensures strict control over peptide chain assembly, purification gradients, and lyophilization cycles.
Independent verification is performed by third-party ISO 17025 accredited laboratories. Every lot undergoes individual testing rather than reliance on skip-lot testing or supplier self-certifications. Chromatograms, mass spectra, and microbiological assays generated during these independent evaluations are linked directly to specific lot numbers and published openly for lab review.
To ensure rapid delivery for ongoing laboratory workflows, PX1 Research dispatches orders standard with same-day shipping (Monday through Friday) originating from our centralized fulfillment hubs in California and Arizona. This dual-location infrastructure reduces transit time and minimizes thermal stress on temperature-sensitive research materials.
Academic institutions, biotechnology firms, and contract research organizations (CROs) demand predictable supply chains and consistent lot quality. Inconsistencies between product batches can jeopardize long-term study validation, leading to wasted resources and unrepeatable data.
PX1 Research supports institutional procurement by offering reserve-lot capabilities, ensuring that longitudinal studies can source identical batch numbers across multi-month experimental phases. Facilities seeking large-quantity procurement or specialized lot reservations can coordinate directly through our wholesale laboratory program.
Every institutional order includes full analytical documentation packages, safety data sheets (SDS), and direct access to our technical support team to assist with compliance auditing and documentation verification. To learn more about our quality control frameworks, visit our central growth hormone secretagogue guide.
What is a tesamorelin coa?
A tesamorelin coa (Certificate of Analysis) is a lot-specific analytical document provided by an independent laboratory verifying the identity, chemical purity (via RP-HPLC), molecular mass (via ESI-MS), and endotoxin concentration (via LAL assay) of a specific batch of synthesized Tesamorelin.
How do I interpret the HPLC chromatogram on a tesamorelin coa?
To interpret an HPLC chromatogram, examine the principal peak, which corresponds to intact Tesamorelin. Calculate purity by dividing the integrated area under the main peak by the sum of all integrated peak areas. A compliant COA should reflect a main peak integration representing ≥99.0% purity.
What mass spectrometry details should appear on a tesamorelin COA?
The COA should display an Electrospray Ionization Mass Spectrometry (ESI-MS) spectrum showing the observed mass-to-charge (m/z) ratios. The calculated molecular weight derived from these peaks must match Tesamorelin's theoretical molecular weight of approximately 5135.9 Da within instrument margin of error.
Why is endotoxin testing critical for tesamorelin in vitro assays?
Endotoxin testing ensures that the peptide lot is free of Gram-negative bacterial lipopolysaccharides. High endotoxin levels trigger non-specific inflammatory signaling in cell cultures, confounding experimental data and compromising cell viability.
What is the standard purity threshold for research-grade tesamorelin?
High-grade research peptides like Tesamorelin must meet or exceed a 99.0% HPLC purity threshold to prevent truncated amino acid sequences or chemical impurities from interfering with receptor binding assays.
How should lyophilized tesamorelin be stored upon arrival?
Lyophilized Tesamorelin should be stored in a freezer at -20°C to -80°C upon arrival, protected from light and moisture. Sealed lyophilized vials stored at these temperatures retain chemical stability for extended research periods.
What diluents are suitable for reconstituting tesamorelin for laboratory use?
Common laboratory diluents include sterile bacteriostatic water (0.9% benzyl alcohol) for multi-use analytical sampling or sterile physiological saline (0.9% NaCl) for immediate cellular assay applications, depending on protocol parameters.
How does tesamorelin compare to CJC-1295 no DAC in research applications?
Tesamorelin is a 44-amino-acid GHRH analog modified with a trans-3-hexenoic acid group, while CJC-1295 No DAC is a tetrasubstituted 29-amino-acid analog. Both target GHRH receptors, but they exhibit distinct half-life profiles and receptor binding kinetics in vitro.
Can research facilities order bulk tesamorelin with lot-matched COAs?
Yes, institutional facilities can order bulk quantities with verified lot-matched COAs through PX1 Research's wholesale supply program, ensuring lot consistency across large-scale or multi-phase experimental studies.
How does PX1 Research ensure lot-to-lot consistency for GHRH analogs?
PX1 Research ensures lot consistency by manufacturing all peptides in US-based GMP-compliant facilities and validating every individual production batch through third-party ISO 17025 accredited laboratories prior to release.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.